We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Risk Assessment and Treat Compliance in Hypertension Education Trial (RATCHET)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00694239
First Posted: June 10, 2008
Last Update Posted: June 30, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Western Ontario, Canada
The Physicians' Services Incorporated Foundation
Information provided by:
Lawson Health Research Institute
  Purpose
The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.

Condition Intervention
Hypertension Dyslipidemia Behavioral: Knowledge of Cardiovascular Risk Assessment

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension

Resource links provided by NLM:


Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • Medication Compliance [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • Patient perception of cardiovascular risk [ Time Frame: 1 year ]
  • Pilot Feasibility Study [ Time Frame: 1 year ]
  • Blood Pressure [ Time Frame: 1 year ]
  • Cholesterol Level [ Time Frame: 1 year ]
  • Framingham Risk Score (stroke and coronary artery disease) [ Time Frame: 1 year ]

Estimated Enrollment: 100
Study Start Date: May 2007
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: B
Standard Care
Experimental: A
Risk Assessment plus standard care
Behavioral: Knowledge of Cardiovascular Risk Assessment
Knowledge of Cardiovascular Risk Assessment and risk reduction at target BP, reviewed every 3-6 months.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 84 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines

Exclusion Criteria:

  • Lack of written informed consent
  • Previous myocardial infarction
  • Previous stroke
  • Congestive heart failure
  • Stage 3 or greater chronic kidney disease
  • Pregnancy
  • Usage of medication bubble/blister package
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00694239


Locations
Canada, Ontario
University of Western Ontario
London, Ontario, Canada, N6A 5A5
Sponsors and Collaborators
Lawson Health Research Institute
University of Western Ontario, Canada
The Physicians' Services Incorporated Foundation
Investigators
Principal Investigator: Bryan J Har, MD University of Western Ontario, Canada
Principal Investigator: George K Dresser, PhD, MD University of Western Ontario, Canada
  More Information

Additional Information:
Responsible Party: George Dresser, University of Western Ontario
ClinicalTrials.gov Identifier: NCT00694239     History of Changes
Other Study ID Numbers: R-07-053
13014E ( Other Identifier: REB )
First Submitted: June 6, 2008
First Posted: June 10, 2008
Last Update Posted: June 30, 2011
Last Verified: June 2011

Keywords provided by Lawson Health Research Institute:
hypertension
compliance

Additional relevant MeSH terms:
Hypertension
Dyslipidemias
Vascular Diseases
Cardiovascular Diseases
Lipid Metabolism Disorders
Metabolic Diseases